Company Filing History:
1 out of 3,923 
1 out of 151 
1 out of 33 
Years Active: 2013
Title: Innovations of Andreas Sailer
Introduction
Andreas Sailer is a notable inventor based in Munich, Germany. He has made significant contributions to the field of medical research, particularly in the area of viral interactions and therapeutic development. His work has implications for understanding and treating diseases associated with the Epstein-Barr virus.
Latest Patents
Andreas Sailer holds a patent titled "Methods of identifying a modulator that inhibits the binding between Epstein-Barr virus induced receptor 2 and cholesterol derived ligands." This invention relates to modulators that affect the interaction between Epstein-Barr Virus induced receptor-2 (EBi2) and specific cholesterol derivatives. The modulator may be a small chemical molecule, antibody, or other therapeutic protein. Additionally, the patent describes methods of medical treatment and ways to identify these modulators.
Career Highlights
Throughout his career, Andreas has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Irm LLC. His experience in these organizations has allowed him to develop and refine his innovative ideas in medical treatments.
Collaborations
Andreas has collaborated with several professionals in his field, including Birgit Uta Baumgarten and Francois Gessier. These partnerships have contributed to the advancement of his research and the successful development of his patent.
Conclusion
Andreas Sailer is a distinguished inventor whose work on modulators related to the Epstein-Barr virus showcases his commitment to advancing medical science. His contributions are vital for future therapeutic developments.